Under Armour Plagued With Supply Constraints and 4 Stock Analyses Not to Ignore

Under Armour, Inc. (NYSE:UA):  UBS said Under Armour, Inc. is experiencing supply chain constraints that could limit their third quarter revenue upside. The analyst believes Under Armour’s premium valuation reflects consensus expectations for the third quarter upside and maintains their Neutral rating with an increased price target up from $54 to$57.

Don’t Miss: Are Kraft’s Stocks a Buy Amidst the Spin-Off?

Red Hat, Inc. (NYSE:RHT):  After Red Hat, Inc. reported roughly in-line second quarter results, Pacific Crest remains bullish on the stock’s long-term outlook. The firm doesn’t expect the company’s positive catalysts to materialize until fiscal year 2014, but they maintain an Outperform rating on their shares.

Lorillard, Inc. (NYSE:LO):  According to UBS, Lorillard, Inc.’s weakness is due to the European Union’s Tobacco directive.

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR):  After the company disclosed that they were aware of a United States government investigation of their promotional practices, Roth Capital reduced their target on Questcor Pharmaceuticals, Inc. The firm believes that the news created uncertainty but may be only a headline risk and they reiterate a Buy rating on the shares.

Santarus Inc. (NASDAQ:SNTS):  After meeting with Santarus Inc.’s management, Roth Capital believes that all of the company’s programs remain on track while its Ruconest drug could surpass expectations. The firm maintains a Buy rating on the stock.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>